MedPath

NICARDIPINE HYDROCHLORIDE

NICARDIPINE HYDROCHLORIDE INJECTION 25mg/10mL (2.5 mg/mL) 10mL VIAL

Approved
Approval ID

9d898911-d811-2a78-e053-2995a90af784

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 23, 2020

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NICARDIPINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1482
Application NumberNDA022276
Product Classification
M
Marketing Category
C73594
G
Generic Name
NICARDIPINE HYDROCHLORIDE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 23, 2020
FDA Product Classification

INGREDIENTS (4)

NICARDIPINE HYDROCHLORIDEActive
Quantity: 25 mg in 10 mL
Code: K5BC5011K3
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
2,4-DIHYDROXYBENZOIC ACIDInactive
Code: LU39SC9JYL
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NICARDIPINE HYDROCHLORIDE - FDA Drug Approval Details